Kraig Biocraft Laboratories Files for Expanded Investment License to Fuel Spider Silk Production Growth
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that it has filed for an expanded investment license for its production subsidiary, Prodigy Silk. The filing adds capital for the next phase of growth in recombinant spider silk production. Over the last two years, Kraig Labs has significantly expanded its ability to produce spider silk; now it is funding additional scale.
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.comSummary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.